Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer

por Vasconcelos-dos-Santos, Andréia, Oliveira, Isadora A., Lucena, Miguel Clodomiro, Mantuano, Natalia Rodrigues, Whelan, Stephen A., Dias, Wagner Barbosa, Todeschini, Adriane Regina
Publicado 2015

CD43 sialoglycoprotein modulates cardiac inflammation and murine susceptibility to Trypanosoma cruzi infection

por Alisson-Silva, Frederico, Mantuano, Natália Rodrigues, Lopes, Ana Luiza, Vasconcelos-dos-Santos, Andréia, Vale, André Macedo, Costa, Miriam Maria, Cannon, Judy L., Oliveira, Ana Carolina, Todeschini, Adriane R.
Publicado 2019

Expression of leukosialin (CD43) defines a major intrahepatic T cell subset associated with protective responses in visceral leishmaniasis

por Nico, Dirlei, Maran, Naiara, Santos, Leonardo, Ramos-Junior, Erivan Schnaider, Mantuano, Natália Rodrigues, Coutinho, Joseane Lima Prado, Vale, Andre Macedo, Freire-de-Lima, Celio Geraldo, Todeschini, Adriane, Rodrigues, Juliany Cola Fernandes, Palatnik-de-Sousa, Clarisa Beatriz, Morrot, Alexandre
Publicado 2015

Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade

por Stanczak, Michal A., Mantuano, Natalia Rodrigues, Kirchhammer, Nicole, Sanin, David E., Jacob, Francis, Coelho, Ricardo, Everest-Dass, Arun V., Wang, Jinyu, Trefny, Marcel P., Monaco, Gianni, Bärenwaldt, Anne, Gray, Melissa A., Petrone, Adam, Kashyap, Abhishek S., Glatz, Katharina, Kasenda, Benjamin, Normington, Karl, Broderick, James, Peng, Li, Pearce, Oliver M.T., Pearce, Erika L., Bertozzi, Carolyn R., Zippelius, Alfred, Läubli, Heinz
Publicado 2022